{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:21:05Z","timestamp":1793215265182,"version":"4.5.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T00:00:00Z","timestamp":1390521600000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.immuni.2013.01.004","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T10:58:06Z","timestamp":1359025086000},"page":"13-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1002,"title":["Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Wei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren\u00a0J.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2013.01.004_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T\u00a0cells","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1101\/gad.14.5.521","article-title":"The MAR-binding protein SATB1 orchestrates temporal and spatial\u00a0expression of multiple genes during T-cell development","volume":"14","author":"Alvarez","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2013.01.004_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib4","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.4049\/jimmunol.176.9.5255","article-title":"Interleukin-2-dependent mechanisms of tolerance and immunity in\u00a0vivo","volume":"176","author":"Antony","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1084\/jem.176.5.1265","article-title":"Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling","volume":"176","author":"Arima","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib7","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1074-7613(00)80605-6","article-title":"Helper T\u00a0cell differentiation is controlled by the cell cycle","volume":"9","author":"Bird","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib9","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1182\/blood.V83.10.2995.2995","article-title":"Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes","volume":"83","author":"Bosco","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.7973657","article-title":"Prevention of T\u00a0cell anergy by signaling through the gamma c chain of the IL-2 receptor","volume":"266","author":"Boussiotis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T\u00a0cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1073\/pnas.0812851107","article-title":"Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments","volume":"107","author":"Busse","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib14","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1073\/pnas.90.18.8464","article-title":"Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression","volume":"90","author":"Cao","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib15","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.1003961","article-title":"The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development","volume":"187","author":"Castro","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.med.56.090203.104142","article-title":"Gene therapy for severe combined immunodeficiency","volume":"56","author":"Cavazzana-Calvo","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1110\/ps.0218903","article-title":"A reinterpretation of the dimerization interface of the N-terminal domains of STATs","volume":"12","author":"Chen","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.immuni.2013.01.004_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ni.2293","article-title":"TRIM28 prevents autoinflammatory T\u00a0cell development in\u00a0vivo","volume":"13","author":"Chikuma","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","article-title":"Differential regulation of T-cell growth by IL-2 and IL-15","volume":"108","author":"Cornish","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib21","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1073\/pnas.0400339101","article-title":"Interleukin 2 plays a central role in Th2 differentiation","volume":"101","author":"Cote-Sierra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib22","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.4049\/jimmunol.155.12.5690","article-title":"Endogenous IL-2 contributes to T\u00a0cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection","volume":"155","author":"Cousens","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T\u00a0cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2009-06-225987","article-title":"An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes","volume":"115","author":"Curtale","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib25","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.4049\/jimmunol.178.7.4022","article-title":"Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells","volume":"178","author":"Davidson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib26","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.133.6.3054","article-title":"Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen","volume":"133","author":"Depper","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib27","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1073\/pnas.82.12.4230","article-title":"Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene","volume":"82","author":"Depper","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.imbio.2008.07.026","article-title":"CD25 as an immune regulatory molecule expressed on myeloid dendritic cells","volume":"213","author":"Driesen","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.immuni.2013.01.004_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2079","article-title":"Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T\u00a0cells","volume":"12","author":"Feau","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/352803a0","article-title":"Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A","volume":"352","author":"Flanagan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","article-title":"PI3K: downstream AKTion blocks apoptosis","volume":"88","author":"Franke","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1073\/pnas.93.5.2077","article-title":"Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation","volume":"93","author":"Friedmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V98.3.877","article-title":"Defective expression of the interleukin-2\/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency","volume":"98","author":"Gilmour","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib34","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","article-title":"Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15","volume":"13","author":"Giri","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2013.01.004_bib35","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.150.10.4244","article-title":"A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression","volume":"150","author":"Godfrey","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib36","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni0901-882","article-title":"Inducible IL-2 production by dendritic cells revealed by global gene expression analysis","volume":"2","author":"Granucci","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.157.2.851","article-title":"Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1","volume":"157","author":"Gruss","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09108.x","article-title":"Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?","volume":"157","author":"Harrison","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.immuni.2013.01.004_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.129.1.55","article-title":"Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains","volume":"129","author":"H\u00e9mar","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.immuni.2013.01.004_bib40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2011.07.013","article-title":"Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis","volume":"35","author":"Hershko","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib41","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T\u00a0cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib42","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","article-title":"Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity","volume":"188","author":"Imada","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coi.2012.02.001","article-title":"The symphony of the ninth: the development and function of Th9 cells","volume":"24","author":"Jabeen","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1084\/jem.20111174","article-title":"STAT5 is a potent negative regulator of TFH cell differentiation","volume":"209","author":"Johnston","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","article-title":"Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T\u00a0cells favors terminal-effector differentiation in\u00a0vivo","volume":"32","author":"Kalia","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib46","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20070109","article-title":"CREB\/ATF-dependent T\u00a0cell receptor-induced FoxP3 gene expression: a role for DNA methylation","volume":"204","author":"Kim","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib47","doi-asserted-by":"crossref","first-page":"34042","DOI":"10.1074\/jbc.M505833200","article-title":"Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T\u00a0cell receptor and transforming growth factor-beta","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2013.01.004_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","article-title":"Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system","volume":"17","author":"Kim","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.immuni.2013.01.004_bib49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coph.2012.06.008","article-title":"Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease","volume":"12","author":"Kontzias","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.immuni.2013.01.004_bib50","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T\u00a0cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib51","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2013.01.004_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.1969","article-title":"T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR\u03b3t","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","article-title":"Mature T lymphocyte apoptosis\u2014immune regulation in a dynamic and unpredictable antigenic environment","volume":"17","author":"Lenardo","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.med.47.1.229","article-title":"The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling","volume":"47","author":"Leonard","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/35105066","article-title":"Cytokines and immunodeficiency diseases","volume":"1","author":"Leonard","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/300267a0","article-title":"A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor","volume":"300","author":"Leonard","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/311626a0","article-title":"Molecular cloning and expression of cDNAs for the human interleukin-2 receptor","volume":"311","author":"Leonard","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib59","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1073\/pnas.82.18.6281","article-title":"Interleukin 2 receptor gene expression in normal human T lymphocytes","volume":"82","author":"Leonard","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-065X.1995.tb00095.x","article-title":"Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development","volume":"148","author":"Leonard","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2013.01.004_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 \u2018superkine\u2019","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib62","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.1656","article-title":"Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression","volume":"9","author":"Liao","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T\u00a0cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib64","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1128\/MCB.17.7.3714","article-title":"The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites","volume":"17","author":"Lin","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2013.01.004_bib65","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1038\/sj.onc.1203523","article-title":"The role of Stat5a and Stat5b in signaling by IL-2 family cytokines","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2013.01.004_bib66","first-page":"6201","article-title":"Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products","volume":"13","author":"Lin","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2013.01.004_bib67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.immuni.2012.02.017","article-title":"Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function","volume":"36","author":"Lin","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib68","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and regulatory T\u00a0cells in mediating and restraining inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib69","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1084\/jem.166.4.1156","article-title":"Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor","volume":"166","author":"Lowenthal","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(02)00367-9","article-title":"CD4 regulatory T\u00a0cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2","volume":"17","author":"Malek","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2011.10.008","article-title":"Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis","volume":"142","author":"Martin","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib74","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20080526","article-title":"Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T\u00a0cell proliferation and survival","volume":"205","author":"Martins","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T\u00a0cells transformed with HTLV-I","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/312641a0","article-title":"Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T\u00a0cells","volume":"312","author":"Mingari","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib77","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.7973659","article-title":"Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits","volume":"266","author":"Miyazaki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib78","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in\u00a0vitro growth of T\u00a0lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib79","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2818","article-title":"NFAT, immunity and cancer: a transcription factor comes of age","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib80","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1074-7613(00)80389-1","article-title":"An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction","volume":"7","author":"Nakajima","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/369330a0","article-title":"Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling","volume":"369","author":"Nakamura","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib82","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/eji.200636980","article-title":"Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells","volume":"37","author":"Naranjo-G\u00f3mez","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib83","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10875-010-9432-3","article-title":"IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery","volume":"30","author":"Ndhlovu","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/369333a0","article-title":"Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation","volume":"369","author":"Nelson","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib85","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/311631a0","article-title":"Molecular cloning of cDNA encoding human interleukin-2 receptor","volume":"311","author":"Nikaido","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib86","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor","volume":"262","author":"Noguchi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib87","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0092-8674(93)90167-O","article-title":"Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans","volume":"73","author":"Noguchi","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib88","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T\u00a0cells","volume":"327","author":"O\u2019Shea","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib89","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni.2242","article-title":"Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile","volume":"13","author":"Oestreich","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib90","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and foxp3 expression are independent and complementary events required for treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib91","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib92","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib93","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4049\/jimmunol.141.3.849","article-title":"Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T\u00a0cell clones","volume":"141","author":"Paliard","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib94","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T\u00a0cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T\u00a0cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are T(H)2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.molcel.2006.03.010","article-title":"Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in\u00a0vivo","volume":"22","author":"Pavan Kumar","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1074-7613(01)00085-1","article-title":"NFATc1 and NFATc2 together control both T and B cell activation and differentiation","volume":"14","author":"Peng","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","article-title":"Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T\u00a0cells","volume":"32","author":"Pipkin","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib99","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2013.01.004_bib100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ni.2363","article-title":"Aiolos promotes TH17 differentiation by directly silencing Il2 expression","volume":"13","author":"Quintana","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib101","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.immuni.2012.04.006","article-title":"Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1","volume":"36","author":"Ramirez","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib102","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ni.2449","article-title":"Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15","volume":"13","author":"Ring","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib103","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.154.5.1455","article-title":"T cell growth factor receptors.\u00a0Quantitation, specificity, and biological relevance","volume":"154","author":"Robb","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib104","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T\u00a0cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib105","doi-asserted-by":"crossref","first-page":"127ps8","DOI":"10.1126\/scitranslmed.3003634","article-title":"Raising the bar: the curative potential of human cancer immunotherapy","volume":"4","author":"Rosenberg","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib106","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib107","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor","volume":"262","author":"Russell","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib108","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.7973658","article-title":"Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID","volume":"266","author":"Russell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib109","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib110","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib111","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T\u00a0cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CJI.0b013e31821dcb50","article-title":"Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome","volume":"34","author":"Samlowski","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.immuni.2013.01.004_bib113","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.4049\/jimmunol.153.9.3989","article-title":"IL-9 production of naive CD4+ T\u00a0cells depends on IL-2, is synergistically enhanced by a combination of\u00a0TGF-beta and IL-4, and is inhibited by IFN-gamma","volume":"153","author":"Schmitt","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib114","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.188.7.1369","article-title":"The interleukin 2 receptor alpha chain\/CD25 promoter is a target for nuclear factor of activated T\u00a0cells","volume":"188","author":"Schuh","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib115","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib116","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1172\/JCI119858","article-title":"An interleukin-2 receptor gamma chain mutation with normal thymus morphology","volume":"100","author":"Sharfe","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2013.01.004_bib117","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.3095922","article-title":"Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions","volume":"234","author":"Sharon","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib118","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.immuni.2008.04.016","article-title":"Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation","volume":"28","author":"Shi","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.3116668","article-title":"The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities","volume":"238","author":"Siegel","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib121","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.0511161103","article-title":"Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor","volume":"103","author":"Stauber","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib122","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ni.1945","article-title":"The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes","volume":"11","author":"Stittrich","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib123","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib124","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.1631559","article-title":"Cloning of the gamma chain of the human IL-2 receptor","volume":"257","author":"Takeshita","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/302305a0","article-title":"Structure and expression of a cloned cDNA for human interleukin-2","volume":"302","author":"Taniguchi","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1084\/jem.165.1.223","article-title":"Interleukin 2 high-affinity receptor expression requires two distinct binding proteins","volume":"165","author":"Teshigawara","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib155","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/eji.201142203","article-title":"miR-9 enhances IL-2 production in activated human CD4+ T cells by repressing Blimp-1","volume":"42","author":"Thiele","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib128","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib129","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1073\/pnas.83.24.9694","article-title":"Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex","volume":"83","author":"Tsudo","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib130","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.126.4.1393","article-title":"A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T\u00a0cells. I.\u00a0Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells","volume":"126","author":"Uchiyama","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4049\/jimmunol.176.1.237","article-title":"IL-27 limits IL-2 production during Th1 differentiation","volume":"176","author":"Villarino","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2005-08-3507","article-title":"CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in\u00a0vivo: additional mechanisms of T-cell inhibition","volume":"108","author":"von Bergwelt-Baildon","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib133","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib134","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/sj.onc.1210368","article-title":"Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia\/lymphoma","volume":"26","author":"Waldmann","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2013.01.004_bib135","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI111379","volume":"73","author":"Waldmann","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2013.01.004_bib136","first-page":"105","article-title":"Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy","volume":"14","author":"Waldmann","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib137","article-title":"Phase I trial of IL-15 transpresentation blockade using humanized Mik-Beta-1 monoclonal antibody in patients with T-cell large granular lymphocytic leukemia","author":"Waldmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib138","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.166.4.1055","article-title":"The interleukin 2 receptor. Functional consequences of its bimolecular structure","volume":"166","author":"Wang","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib139","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.1117893","article-title":"Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors","volume":"310","author":"Wang","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib140","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1182\/blood-2008-09-181156","article-title":"microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T\u00a0cells","volume":"113","author":"Weitzel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2013.01.004_bib141","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1126\/science.1840704","article-title":"Identification of a zinc finger protein that inhibits IL-2 gene expression","volume":"254","author":"Williams","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.immuni.2013.01.004_bib142","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","article-title":"Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T\u00a0cells","volume":"441","author":"Williams","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2013.01.004_bib143","first-page":"25","article-title":"Small-molecule inhibitors of IL-2\/IL-2R: lessons learned and applied","volume":"348","author":"Wilson","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib144","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/sj.onc.1205262","article-title":"Induction of the interleukin-2\/15 receptor beta-chain by the EWS-WT1 translocation product","volume":"21","author":"Wong","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2013.01.004_bib145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","article-title":"FOXP3 controls regulatory T\u00a0cell function through cooperation with NFAT","volume":"126","author":"Wu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2013.01.004_bib146","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nm.2365","article-title":"A\u00a0role\u00a0for\u00a0interleukin-2 trans-presentation in dendritic cell-mediated T\u00a0cell activation in humans, as revealed by daclizumab therapy","volume":"17","author":"Wuest","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib147","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1073\/pnas.212214999","article-title":"IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes","volume":"99","author":"Xue","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2013.01.004_bib148","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib149","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.4049\/jimmunol.172.8.4691","article-title":"Preferential activation of an IL-2 regulatory sequence transgene in TCR gamma delta and NKT cells: subset-specific differences in IL-2 regulation","volume":"172","author":"Yui","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T\u00a0cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib151","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20060066","article-title":"T helper type 1-specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-gamma promoter are Stat4 dependent","volume":"203","author":"Zhang","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2013.01.004_bib152","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T\u00a0cells in\u00a0vivo by IL-15","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2013.01.004_bib153","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T\u00a0cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2013.01.004_bib154","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761313000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761313000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:59:29Z","timestamp":1761033569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761313000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1074761313000113"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2013.01.004","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2013.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}